Work

Long-Term Safety and Efficacy of Deferasirox (Exjade®) In Transfused Patients with Sickle Cell Disease Treated for up to 5 Years

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.845.845

Authors: Elliott Vichinsky, Francoise Bernaudin, Gian Luca Forni, Renee Gardner, Kathryn Hassell, Matthew M. Heeney, Baba Inusa, Abdullah Kutlar, Peter A. Lane, Liesl Mathias, John B. Porter, Cameron K Tebbi, Felicia L. Wilson, Louis Griffel, Wei Deng, Vanessa Giannone, Thomas D. Coates

Institutions: Hôpital Intercommunal de Créteil, Ente Ospedaliero Ospedali Galliera, Louisiana State University, Louisiana State University Health Sciences Center New Orleans, University of Colorado Health, University of Colorado Denver, Boston Children's Hospital, Evelina London Children's Healthcare, Augusta University, Emory University, Children's Healthcare of Atlanta, Loma Linda University Medical Center, University College London, St. Joseph's Children's Hospital, University of South Alabama, Novartis (United States), Children's Hospital Los Angeles

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1747646164

FWCI:

Cites:

Cited by: 2

Related to: 10